Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia

Intravenous flucloxacillin is one of the most frequently used high‐dose penicillin therapies in hospitalized patients, forming the cornerstone treatment of invasive Staphylococcus aureus infection. Being a nonreabsorbable anion, flucloxacillin has been suggested to cause hypokalaemia, although the f...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijden, Charlotte D.C.C., Duizer, Marleen L., Fleuren, Hanneke W.H.A., Veldman, Bart A., Sprong, Tom, Dofferhoff, Anton T.S.M., Kramers, Cornelis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955408/
https://www.ncbi.nlm.nih.gov/pubmed/31026083
http://dx.doi.org/10.1111/bcp.13969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955408/
https://www.ncbi.nlm.nih.gov/pubmed/31026083
http://dx.doi.org/10.1111/bcp.13969

Ejemplares similares